Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients. (SMART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00738257
Recruitment Status : Completed
First Posted : August 20, 2008
Last Update Posted : May 17, 2010
Sponsor:
Information provided by:
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2004
Study Completion Date : No date given